Deka Bank Deutsche Girozentrale Cerus Corp Transaction History

Deka Bank Deutsche Girozentrale

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 12, 2021	SELL	$5.25 - $8.56 $532,875 - $868,840	-101,500 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$5.78 - $7.47 $586,670 - $758,205	101,500 New	101,500 $637,000
Q4 2019 Feb 04, 2020	SELL	$3.84 - $4.86 $447,360 - $566,190	-116,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $600,210 - $747,175	-123,500 Reduced 51.46%	116,500 $566,000
Q2 2019 Aug 01, 2019	BUY	$4.51 - $6.6 $874,940 - $1.28 Million	194,000 Added 421.74%	240,000 $1.19 Million
Q1 2019 May 10, 2019	BUY	$5.16 - $6.85 $43,860 - $58,225	8,500 Added 22.67%	46,000 $352,000
Q4 2018 Feb 12, 2019	SELL	$4.89 - $7.16 $41,565 - $60,860	-8,500 Reduced 18.48%	37,500 $183,000
Q3 2018 Nov 09, 2018	SELL	$6.89 - $7.78 $6,890 - $7,780	-1,000 Reduced 2.13%	46,000 $0
Q1 2018 May 03, 2018	SELL	$3.56 - $5.74 $3,560 - $5,740	-1,000 Reduced 2.08%	47,000 $259,000
Q3 2017 Nov 06, 2017	BUY	$2.22 - $2.73 $106,560 - $131,040	48,000	48,000 $122,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $312M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.